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Abstract 
Purpose: To examine the age-dependent alterations and the longitudinal course of 
subbasal nerve plexus (SNP) morphology in healthy individuals. 
Methods: Sixty-four healthy participants had ocular screening, health and metabolic 
assessment as well as laser-scanning corneal confocal microscopy examination at 
baseline and at 12-month intervals for three years. At each annual visit, eight central 
corneal images of the SNP were selected and analyzed using a fully-automated 
analysis system to quantify corneal nerve fiber length (CNFL). Two linear mixed 
model approaches were fitted to examine the relationship between age and CNFL 
and the longitudinal changes of CNFL over three years. 
Results: At baseline, mean age was 51.9 ± 14.7 years. The cohort was gender 
balanced (χ2=0.56, p=0.45). Age (t=1.6, p=0.12) and CNFL (t= -0.50, p=0.62) did not 
differ between genders. Fifty-two participants completed the 36-month visit and 49 
participants completed all visits. Age had a significant effect on CNFL (F (1, 33)=5.67, 
p=0.02) with a linear decrease of 0.05 mm/mm2 in CNFL per one year increase in 
age. No significant change in CNFL was observed over the 36-month period (F (1, 
55)=0.69, p=0.41).  
Conclusions: CNFL showed a stable course over a 36-month period in healthy 
individuals, although there was a slight linear reduction in CNFL with age. The 
findings of this study have implications for understanding the time-course of the 
effect of pathology and surgical or therapeutic interventions on the morphology of the 
SNP and serves to confirm the suitability of CNFL as a screening/monitoring marker 
for peripheral neuropathies. 
Keywords: Corneal confocal microscopy; subbasal nerve plexus; age; natural 
history 
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Introduction 1 
In vivo corneal confocal microscopy (CCM) is a rapid, non-invasive and reiterative 2 
technique which enables microstructural evaluation of the human cornea at high 3 
resolution. The anatomical location and transparency of the cornea make this tissue 4 
structure ideally suited for confocal microscopic assessment.1 Image acquisition 5 
using CCM from different corneal layers and structures helps both clinicians and 6 
researchers to extract important information in respect to alterations induced by 7 
various ocular and systemic conditions. 8 
The subbasal nerve plexus (SNP), which is a dense array of nerves located between 9 
the corneal basal epithelium and Bowman’s layer, is the main corneal nerve 10 
structure studied in vivo using CCM as a result of distinct morphologic attributes 11 
such as length of the nerve bundles and their parallel arrangement in relation to the 12 
ocular surface. Structural analysis of the SNP has been used to evaluate ocular 13 
conditions such as dry eye, ocular allergy and glaucoma,2-5 corneal ectasia and 14 
dystrophies,6, 7 the effect of contact lens wear8, 9 and assessment of nerve 15 
regeneration after penetrating keratoplasty10 and different forms of refractive 16 
surgery.11, 12 Further to ocular applications, CCM has been deployed to assess small 17 
nerve fiber pathology induced by several systemic conditions including diabetes,13, 14 18 
Fabry disease,15 idiopathic neuropathy16 and chemotherapy.17 19 
Given the utility of SNP evaluation in screening, detection and monitoring of a wide 20 
range of systemic and corneal neuropathies, it is important to understand how aging 21 
might affect this nerve plexus. However, there is inconsistency in the literature with 22 
respect to the relationship between age and neural morphometric change in the SNP 23 
using both ex vivo and in vivo techniques. While a number of studies have reported 24 
4 
 
no significant change in the subbasal nerve morphology with age,18-20 others have 1 
reported a decrease in nerve density with age21-23 and there is also uncertainty as to 2 
the age at which SNP structural loss become significant. Furthermore, no data is 3 
available concerning the dynamic morphologic changes of corneal nerves in health 4 
or disease over time. 5 
The two primary objectives of this study were to investigate: (1) the relationship 6 
between age and corneal nerve fiber length (CNFL), which is the most standardized, 7 
generally adopted and frequently reported SNP morphometric parameter obtained 8 
from CCM; and (2) longitudinal changes of CNFL over three years in healthy human 9 
corneas.  10 
Methods 11 
Study participants 12 
Following approval from the research ethics committee of Queensland University of 13 
Technology (Queensland, Australia) and obtaining written informed consent, 64 14 
healthy participants were enrolled. Participants were recruited from the community in 15 
Brisbane, Australia, as a part of 4-year LANDMark (Longitudinal Assessment of 16 
Neuropathy in Diabetes using novel ophthalmic Markers) study.14 Exclusion criteria 17 
were: history of corneal surgery, trauma or disease, glaucoma, evidence of corneal 18 
compromise, ocular and systemic diseases (e.g. diabetes) that might have adversely 19 
affected the cornea and history of neuropathy. These criteria were reassessed at 20 
each annual visit.   21 
All participants underwent assessment of visual acuity, slit lamp biomicroscopy and 22 
tonometry and all corneas were confirmed to be within clinical norms. Four 23 
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participants were current soft contact lens wearers and were asked to refrain from 1 
contact lens wear on the day of examinations. Since previous studies investigating 2 
the impact of contact lens wear on morphologic changes in subbasal nerves using 3 
CCM have failed to demonstrate any impact24-26, we did not exclude contact lens 4 
wearers in the present study. All participants were observed at baseline and the 5 
examinations continued at 12-month intervals over three years for a total of four 6 
visits. The study was conducted in accordance with the tenets of the Declaration of 7 
Helsinki.  8 
Corneal confocal microscopy and image analysis 9 
At each visit, all participants underwent corneal confocal microscopy examination 10 
approximately at corneal apex using the Heidelberg Retina Tomograph III with 11 
Rostock Corneal Module (Heidelberg Engineering GmbH, Dossenheim, Germany). 12 
One eye (on the side of hand dominance) was selected and anaesthetized with a 13 
drop of 0.4% benoxinate hydrochloride (oxybuprocaine hydrochloride; Bausch & 14 
Lomb, NSW, Australia). Eight central corneal images per participants, displaying in-15 
focus nerves and not overlapping more than 20%,27 were selected by inspection and 16 
analyzed using a fully-automated analytical system28 to quantify CNFL, which is 17 
defined as total length of all nerve fibers in the CCM image (in units of mm/mm2). 18 
Since this study was a part of a larger project designed to investigate the utility of 19 
ophthalmic markers of neuropathy in diabetic and healthy individuals, we sought to 20 
determine intra- and interobserver variability of CNFL measurement in a study of 16 21 
and 11 participants, respectively. Participants underwent CCM examination on two 22 
occasions (same observer for intraobserver and different observers for interobserver 23 
variability) on the same day of examination followed by automated CNFL 24 
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quantification using the above procedure. Intraclass correlation coefficient and 1 
coefficient of variability for intraobserver were 0.90 and 5.7% and for interobserver 2 
were 0.94 and 8.1%, respectively. 3 
Blood biochemistry and health parameters 4 
At each visit, blood biochemistry measures (HbA1c and lipid profile) were assayed by 5 
a local certified pathology laboratory, and clinical measures (height, weight and 6 
blood pressure) were assessed by a research nurse. 7 
Statistical analysis 8 
Statistical analysis of the data was performed using SPSS (version 21). Normal 9 
distribution of the data was determined with the Kolmogorov-Smirnov test. 10 
Quantitative variables are expressed by the mean ± standard deviation (SD) unless 11 
otherwise indicated. For the analysis of the categorical variables, the χ2 test was 12 
applied. The independent samples t-test was used to compare age and CNFL 13 
between genders. Bivariate correlation was used, as appropriate, for assessment of 14 
association of CNFL with alcohol consumption and absolute changes in CNFL with 15 
HbA1c. Welch ANOVA was used to test the CNFL difference among age groups at 16 
baseline visit. Differences in characteristics from baseline visit to year-3 visit were 17 
assessed using paired sample t-test (normally distributed) and nonparametric 18 
Wilcoxon test (not-normally distributed).  19 
To analyze longitudinal data using the linear mixed model (LMM) procedure in the 20 
SPSS statistical software, the horizontal data format were converted to vertical 21 
structure; thus, there were four rows per participant corresponding to the four 22 
measurements collected over time on each participant. The relationship between 23 
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age and CNFL and the changes of CNFL over 3-year period were examined by 1 
fitting two linear mixed models with restricted maximum likelihood estimation. The 2 
first model (LMM1) contained CNFL, age at each annual visit and gender. CNFL was 3 
defined as dependent variable. Age (time-varying predictor variable) and gender 4 
(time-invariant variable) were specified as covariate and factor, respectively. Age, 5 
gender and the gender*age interaction were specified as fixed effects and Type III 6 
method of sums of squares was used. In the random effects dialog box, unstructured 7 
covariance type was chosen and age was entered in the model.   8 
The assessment of linear change of CNFL over time (36 months) was carried out by 9 
fitting the second model (LMM2) in which CNFL was specified as dependent variable 10 
and time which was a variable capturing the order of observation, was defined as 11 
repeated variable. We assumed that the correlation between two adjacent CNFL 12 
measurements declines across measurement occasions, therefore first order 13 
autoregressive covariance structure was chosen. CNFL and gender were considered 14 
as dependent variable and factor, respectively. Time and age at enrolment were 15 
assigned as covariates.   16 
Results 17 
The demographic and clinical data of participants at baseline and 36-month visits are 18 
given in Table 1. A total of 64 participants completed the baseline visit and 52 19 
completed the 36-month visit. The baseline cohort included 29 males and 35 females 20 
(χ2 = 0.56, p = 0.45). Mean age was 51.9 ± 14.7 years. Age (males: 55.1 ± 14.0 21 
years, females: 49.3 ± 15.0 years, p = 0.12) and CNFL (males: 17.7 ± 3.6 mm/mm2, 22 
females: 18.2 ± 3.7 mm/mm2, p = 0.62) did not differ between genders. Four 23 
participants (6%) reported to be current smokers with an average 19 cigarettes per 24 
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day. CNFL was not significantly different between current smokers and non-smokers 1 
(t = 1.3, p = 0.20). Fifty-two participants (81%) reported current alcohol use with an 2 
average 5.9 units/week. No significant correlation was found between alcohol 3 
consumption (units/week) and CNFL (Spearman's Rho, rs = - 0.09, p = 0.53) at 4 
baseline visit. Nine participants were taking antidepressants during study period. No 5 
association was observed between using antidepressant drugs and mean CNFL at 6 
annual visits (independent samples t-test, p = 0.88, p = 0.31, p = 0.32 and p = 0.86 7 
at baseline, year 1, year 2 and year 3 visits, respectively). 8 
Participants were divided into three age groups:  group 1 aged < 45 years (n = 19), 9 
group 2 aged 45 - 59 years (n = 25) and group 3 aged ≥ 60 years (n = 20) (Table 2). 10 
There was not a significant effect of age groups on CNFL (Welch ANOVA, p = 0.50). 11 
Apart from a clinically insignificant decline in HbA1c (p < 0.01), over 36 months, there 12 
were no significant changes to health, metabolic or ocular screening measures 13 
(Table 1). There was also no correlation between absolute changes in CNFL and 14 
HbA1c from baseline to the 36-month visit (Pearson, r = 0.11, p = 0.49).  15 
LMM1 was deployed to determine the association of age and CNFL. Using backward 16 
elimination procedure, fixed effects of gender*age interaction (F (1, 30) = 0.02, p = 17 
0.89) and gender (F (1, 16) = 0.04, p = 0.85) were sequentially removed. Type III tests 18 
of fixed effects revealed that there was a significant influence of age (F (1, 33) = 5.67, 19 
p = 0.02) on CNFL. Estimates of fixed effects and covariance parameters are 20 
presented in Table 3. 21 
The natural history of CNFL over the 36-month observation period is depicted 22 
graphically in Figure 1. LMM2 revealed that the linear effect of time (F (1, 55) = 0.69, p 23 
= 0.41), gender (F (1, 61) = 1.10, p = 0.30), age at enrolment (F (1, 60) = 1.13, p = 0.29) 24 
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and time*gender interaction (F (1, 55) = 1.41, p = 0.24) were not statistically significant. 1 
To further eliminate the potential effect of antidepressants on the longitudinal course 2 
of CNFL in healthy participants, LMM2 was repeated excluding participants who 3 
were receiving antidepressant therapy during study period. The results were similar 4 
to the total cohort with no significant effect of time (p = 0.47), gender (p =0.25), age 5 
at enrolment (p =0.29) and time*gender interaction (p =0.16). 6 
Discussion 7 
The feasibility of assessing corneal nerve morphology via CCM and the promising 8 
role of these structural parameters as an indicator of corneal nerve recovery 9 
following surgical and pharmacological intervention, and the potential for screening 10 
for peripheral neuropathies, has led to an increase in the scope of this approach. An 11 
increasing number of studies showing a relationship between quantitative analysis of 12 
the SNP parameters and various ocular and systemic pathological conditions or 13 
surgical-induced changes, highlights the importance of understanding the natural 14 
morphometric behavior of the SNP over time.  15 
In this longitudinal prospective study, participants were followed over 36 months with 16 
repeated monitoring of ocular, health and CNFL measures. At baseline, our cohort 17 
was gender balanced (45% male) and age was not significantly different between 18 
genders. The gender of participants was also shown to have no influence on CNFL. 19 
While the variability from the mean of CNFL increased with age (Table 2), mean 20 
CNFL between the groups was not significantly different. This finding is consistent 21 
with those of Patel et al19 who found no significant differences in mean CNFL 22 
between three age groups in a cohort of 60 healthy participantsConversely, 23 
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Grupcheva et al29 reported a significant difference in mean CNFL between two age 1 
groups (25 ± 5 years vs. 70 ± 5 years) of 50 participants. 2 
Using laser-scanning CCM, a great diversity has been reported in CNFL 3 
quantification in healthy individuals.22, 26, 30, 31 The mean central corneal nerve fiber 4 
length in the current study was 18.0 ± 3.6 mm/mm2 which is similar to that reported 5 
by Wu et al (18.0 ± 4.0 mm/mm2)26, but lower than those of Niederer et al (20.3 ± 6.5 6 
mm/mm2)22 and Parissi et al (18.6 ± 4.8 mm/mm2, right eyes and automated 7 
analysis).23 Differences in methodologies including number of participants, selected 8 
images, age range and method of CNFL analysis may account for differing results.  9 
One strength of the present study was our consistency in respect to the location of 10 
corneal assessment (central), which entitled a rigid sampling paradigm for the central 11 
region of the cornea, including the number of selected images and the use of an 12 
objective, fully-automated analysis system for image analysis. Employment of a fully-13 
automated analysis system facilitated reliable and objective quantification of CNFL, 14 
which was important for ascertaining the natural course of this CCM measure. It has 15 
been demonstrated that fully-automated analysis of CNFL obtained from laser-16 
scanning CCM images agrees very well with semi-automated and manual analysis28 17 
and yields results with a high level of reproducibility. 18 
In the current literature, there is some discrepancy among studies as to whether 19 
corneal nerve structure changes with age. While subbasal nerve fiber density has 20 
been reported to reduce with age in an ex vivo study in 22 donor corneas aged from 21 
19 to 80 years,21 Marfurt et al18 using immunohistochemical staining technique found 22 
no significant correlation between CNFL and age in corneas of six donors aged 19 - 23 
11 
 
78 years. Such a disagreement exists among studies using in vivo CCM as well.19, 20, 1 
22, 23 2 
The usual design employed in previous studies reporting the effect of age on corneal 3 
nerve morphology has been cross-sectional, in which measurements are made on 4 
participants of various ages and the detected differences are attributed to the effect 5 
of age. However, such results do not necessarily reflect real age changes. A 6 
longitudinal design with serial measurements in the same individuals over time 7 
allows true age changes for individuals to be determined. The findings of the current 8 
study (LMM1, Table 3) showed that there was a significant linear decrease in the 9 
CNFL with age. The mean estimated initial status (at birth) and the linear change 10 
rate (per year) of CNFL for the total group were 20.94 mm/mm2 and - 0.05 mm/mm2, 11 
respectively. This suggests that 1 mm/mm2 reduction in central corneal nerve 12 
morphology would require 20 years to take place in normal participants. Although 13 
they are cross-sectional, the results of studies by Niederer et al22 and Parissi et al,23 14 
who reported  a gradual decline in CNFL with age at a rate of 0.9% per year and 15 
0.30% per year, respectively,  are in general agreement with our finding. 16 
Although marginally non-significant at α < 0.05, the estimated covariance of the two 17 
random effects in the LMM1 i.e. intercept and age (β = -0.30, p = 0.05) was negative 18 
(Table 3), which suggests individuals with high CNFL had a slower linear decrease, 19 
whereas individuals with low CNFL had a faster decrease with age. There is also 20 
evidence of significant variance in these random effects (β = 0.01, p = 0.02) which 21 
indicates that the slopes tend to vary from individual to individual. 22 
Apart from HbA1c with a minor (0.1 %NGSP) but statistically significant difference, 23 
the average of all clinical metabolic and ocular screening measures remained stable 24 
12 
 
from baseline to 36-month visit. LMM2 showed that in this 3-year longitudinal study, 1 
CNFL appeared to be stable as a function of time. The relationship of time with 2 
CNFL change did not vary depending on gender, yielding a similar longitudinal 3 
pattern of CNFL over three years for males and females. It is also worth noting that 4 
while neuronal plasticity and regeneration can be influenced by antidepressant 5 
treatment,32, 33 when our analysis was restricted to participants who were not 6 
receiving these medications; our results closely resembled those from the total 7 
cohort.  8 
No previous study has conducted a longitudinal analysis of corneal nerve 9 
morphology in healthy individuals. The results we present allow us to show, for the 10 
first time, stability of human corneal nerve morphology as assessed by laser-11 
scanning CCM over a 3-year period. Our study is important in demonstrating: (1) 12 
significant association, albeit weak, between CNFL and age and (2) a 3-year 13 
morphometric stability of the SNP in healthy individuals. These data provide in vivo 14 
evidence for stability of this structural parameter in healthy individuals and add a 15 
longitudinal component to the cross-sectional studies demonstrating the dependence 16 
of this parameter with age. The outcomes of this study may improve the ability of 17 
clinicians and researchers to understand the time-course of central corneal 18 
reinnervation following interventions such as kerato-refractive surgeries and 19 
pharmacological treatment, and will assist in the interpretation of longitudinal studies 20 
using CNFL assessment as a screening/monitoring marker for peripheral 21 
neuropathies.   22 
Although we found stability of this measure over a 36-month follow up period, this 23 
finding might not apply to CNFL changes over longer time periods. Furthermore, 24 
these findings are limited to nerve changes in the central cornea, and may not be 25 
13 
 
applicable to other more peripheral regions of the human SNP. More recently, in vivo 1 
wide-field maps of the human SNP have been successfully generated,34, 35 which 2 
might be useful to provide insights into changes in the entire SNP, if this procedure 3 
were to be deployed in longitudinal studies.  4 
In conclusion, the current longitudinal in vivo CCM study confirms a slight reduction 5 
in CNFL as a function of age while there was no significant dynamic morphologic 6 
change over 36 months.  The data of this longitudinal study constitute a better 7 
understanding of SNP in living human cornea in a healthy state, which has 8 
implications in investigating the effect of corneal surgery, known transient or chronic 9 
alterations as a cause of or secondary to local disease or non-invasive indicator of 10 
peripheral neuropathies. 11 
14 
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Tables 
 
Table 1. Clinical demographic, metabolic and ocular screening measures of study 
participants at baseline and 36-month visits.  
Parameter Baseline 36 months p-value  
(paired t-test) 
Age (years) 51.9 ± 14.7 - - 
Gender (male/female) 29/35 24/29 - 
HbA1c (%NGSP) 5.4 ± 0.3 5.3 ± 0.4 <0.01 
Total cholesterol (mmol/L) 5.4 ± 1.2 5.5 ± 1.1 0.86 
HDL (mmol/L) 1.5 ± 0.4 1.5 ± 0.4 0.16 
LDL (mmol/L) 3.4 ± 1.1 3.4 ± 1.0 0.12 
Triglycerides (mmol/L) 1.1 ± 0.5 1.1 ± 0.5 0.22 
Systolic blood pressure (mmHg)  116.0 ± 13.2 116.2 ± 14.0 0.89 
Diastolic blood pressure (mmHg) 72.8 ± 6.9 72.1 ± 8.4 0.67 
Height (cm) 170.2 ± 8.7 170.3 ± 8.8 0.66 
Weight (kg) 75.7 ± 16.2 75.7 ± 13.7 0.48 
BMI (kg/m2) 26.1 ± 5.1 26.1 ± 4.8 0.67 
Visual acuity (LogMAR) 0.04 ± 0.07 0.03 ± 0.08 0.15* 
Intra-ocular pressure (mmHg) 13.1 ± 2.9 13.3 ± 3.1 0.90 
Values shown are mean ± SD, or counts for categorical variables. 
*Wilcoxon test 
 
 
Table 2. Age and corneal nerve fiber length (CNFL) at baseline in three age groups.  
Age groups No. of 
participants 
CNFL (mean ± SD)* 
mm/mm2 
Age (mean ± SD)† 
yrs 
Group 1: <45 yrs 19 18.6 ± 2.3 33.4 ± 8.7 
Group 2: 45-59 yrs 25 18.1 ± 3.2 53.3 ± 4.4 
Group 3: ≥ 60 yrs 20 17.2 ± 4.9 67.8 ± 3.4 
Total group 64 18.0 ± 3.6 51.9 ± 14.7 
* No significant difference among groups (Welch ANOVA statistics = 0.71, p = 0.50); 
† Significant difference among groups (one-way ANOVA, F = 172.8, p < 0.001) 
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Table 3. Estimates of fixed effects and covariance parameters from linear mixed 
model 1 in which the relationship of age and corneal nerve fiber length was 
examined. 
Estimates of fixed effects* 
Parameter Estimate Std. Error p-value 95% CI 
Intercept 20.94 0.89 0.00 19.06 to 22.83 
Age -0.05 0.02 0.02 -0.09 to -0.01 
Estimates of covariance parameters* 
Parameter Estimate Std. Error p-value 95% CI 
Residual 4.25 0.47 <0.001 3.42 to 5.27 
Intercept + age  
 
UN(1,1) 
UN(2,1) 
UN(2,2) 
9.10 
-0.30 
0.01 
5.45 
0.15 
0.004 
0.09 
0.05 
0.02 
2.81 to 29.42 
-0.61 to 0.00 
0.00 to 0.02 
CI: confidence interval; UN: unstructured variance-covariance matrix for random 
effects 
* Dependent variable: corneal nerve fiber length 
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Figure 1. Quantification of corneal nerve fiber length (CNFL) in healthy participants 
over 36 months. CNFL did not change over three years follow up (linear mixed 
model, p = 0.41). Error bars represent mean ± SD. 
 
